A pharmacovigilance study of sirolimus-associated adverse events in organ transplantation
BackgroundSirolimus (rapamycin), an antibiotic discovered in the 1970s, can effectively reduce allograft rejection, and plays an important role in the fields of immunosuppressive therapy and organ transplantation. Therefore, this study aimed to analyze…